喜島 祐子

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Stomach Neoplasms 79%
3. Breast 70%
4. Segmental Mastectomy 64%
5. Neoplasms 42%
6. Esophageal Squamous Cell Carcinoma 37%
7. Mammaplasty 37%
8. Neoplasm Metastasis 36%
9. Lymph Nodes 33%
10. Skin 32%
11. Nipples 22%
12. Sentinel Lymph Node 20%
13. Gastrectomy 20%
14. Adenocarcinoma 18%
15. Stomach 18%
16. HLA Antigens 16%
17. Pancreatic Neoplasms 16%
18. MicroRNAs 15%
19. Human Herpesvirus 4 15%
20. Circulating Neoplastic Cells 15%
21. Lymph Node Excision 15%
22. Fibrinogen 14%
23. Triple Negative Breast Neoplasms 14%
24. Carcinoma 13%
25. Survival 12%
26. Recurrence 12%
27. Therapeutics 11%
28. Fats 11%
29. Transplants 10%
30. Ductal Carcinoma 10%
31. Video-Assisted Surgery 10%
32. Chemoradiotherapy 10%
33. Neutrophils 10%
34. Mastectomy 10%
35. Lymphocytes 10%
36. Thyroidectomy 9%
37. Japan 9%
38. Carcinoma, Intraductal, Noninfiltrating 9%
39. Drug Therapy 9%
40. Extrahepatic Bile Ducts 9%
41. Rhodamines 8%
42. Thoracic Wall 8%
43. Sentinel Lymph Node Biopsy 8%
44. Neoplasm Micrometastasis 8%
45. Neoadjuvant Therapy 8%
46. Neck 7%
47. Margins of Excision 7%
48. Gastrointestinal Neoplasms 7%
49. Dissection 7%
50. Multivariate Analysis 7%